The Scientific Reporters

Exploring Science

Month: June 2020

PhD position in Neuroregeneration/Neural Stem Cell Biology

A PhD position is available in the research group of Dr. Christian Schachtrup in the Institute of Anatomy and Cell Biology at the University of Freiburg. This position is integrated in the newly established DFG-funded SFB/TRR 167 initiative “Development, Function…

COVID-19 may spark diabetes in healthy individuals

Well-respected academics from around the world speculate that COVID-19 not just a risk for diabetic patients, but is also capable of triggering diabetes in healthy people. COVID-19 first erupted in Wuhan, China late last year. Since then scientists are still…

Dual attack: A synthetic peptide could work as a treatment and vaccine for COVID-19.

Ligandal has succeeded in applying its unique peptide-based technology to develop a synthetic peptide acting as both an antidote and a vaccine against COVID-19.  With the whole world racing to find a treatment or vaccine against COVID-19, San Francisco based…

Anencephaly (Open Skull): A rare genetic condition

Anencephaly is a rare neural tube defect, characterized by abnormal development of the brain or the skull. Infants with this condition are usually born without a forebrain and cerebrum.  Anencephaly also known as the open skull is a term used…

Is Dexamethasone an alternative in fight against COVID-19?

Dexamethasone low cost, anti-inflammatory steroid well known in the world of sports is the first drug to reduce death among COVID-19 patients. One of the common symptoms seen among COVID-19 patients is shortness of breath or respiratory failure. Recently, promising…

Advancements in serologic diagnostic tests could put an end to the COVID-19 test crisis

The University of Bologna along with Roche and Hitachi are working on making faster, cheaper diagnostic tests for COVID-19 with the help of electrochemiluminescence (ECL). Currently one of the main reasons for the rising number of COVID-19 cases is due…

No stones being unturned: Fluoxetine to disrupt viral replication in COVID-19 affected patients.

German experts speculate that Fluoxetine- an antidepressant drug can potentially reduce the viral replication in COVID-19 patients. Here’s more… The current COVID-19 pandemic has brought about unparalleled times for humanity. The measures taken to contain the virus have triggered a…

Asymptomatic COVID-19 transmission is very rare says WHO: A myth or truth?

With COVID-19 showing no mercy, and the number of confirmed cases increasing around the world, it is important to find the truth behind the transmission of asymptomatic cases. As the number of COVID-19 cases rising every day, it is important…

Capture Myopathy: A leading cause of death in spotted deer and its solution

Capture myopathy is a non-infectious disease of the muscle, associated with capturing or handling any wild animals in which the muscle fibers do not function properly resulting in muscle weakness, muscle damage, muscle cramps, stiffness, and spasm can also be…

Respiratory failure during COVID-19 could be linked to certain genetic variants

Using data from genome-wide association study, experts speculate that gene variants encoding blood types and a multidisciplinary chromosome 3 could be the reason behind respiratory failure during COVID-19. Though it’s been several months since its first case, COVID-19 still manages…